Observational studyInvestigational new drugs2025

Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.

Yoshihiko Taniguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.